Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Ovarian Cancer × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 54 Breast Neoplasms 37 Fallopian Tube Neoplasms 22 Multiple Myeloma 19 Carcinoma, Ovarian Epithelial 15 Neoplasms 12 Lymphoma 10 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 6 Lymphoma, Large B-Cell, Diffuse 6 Recurrence 5 Hodgkin Disease 4 Breast Neoplasms, Male 4 Solid Tumors 3 Prostatic Neoplasms 3 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Burkitt Lymphoma 3 Sarcoma, Kaposi 2 Sarcoma 2 Peritoneal Neoplasms 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2

Interventions

talazoparib 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Saline Solution 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡